cdmo.directory
← Compare landing

Enable Biotech Ltd vs Pluri

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/enablebiotech/pluri-biotech

CategoryEnable Biotech LtdPluri
Listed sitecdmocdmo
SummaryEnable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.
Services
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Zug, Switzerland
  • Headquarters, Haifa, Haifa, Israel
  • USA Office, USA
CertificationsData not yet provided.
  • FDA · Identifier: U.S. Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.